Bio Path
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $274 |
Gross Profit | -32 | -47 | 233 | |
EBITDA | -2,628 | -3,006 | -3,648 | -2,992 |
EBIT | -2,661 | -3,038 | -3,695 | -3,033 |
Net Income | -2,115 | -1,869 | -3,157 | -3,372 |
Net Change In Cash | 0 | 0 | 0 | 274 |
Free Cash Flow | -3,428 | -3,228 | -1,038 | -1,814 |
Cash | 562 | 4,006 | 188 | 1,052 |
Basic Shares | 3,017 | 1,612 | 647 | 618 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -178 | -178 | -161 | -151 |
EBITDA | -15,761 | -13,690 | -10,279 | -10,731 |
EBIT | -15,843 | -13,868 | -10,440 | -10,882 |
Net Income | -16,078 | -13,835 | -10,437 | -10,856 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -6,671 | |||
Free Cash Flow | -11,535 | -15,124 | -9,987 | -10,960 |
Cash | 1,052 | 10,384 | 23,774 | 13,755 |
Basic Shares | 478 | 363 | 336 | 192 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.70 |
2024-06-30 | -$1.16 |
2024-03-31 | -$4.88 |
2023-12-31 | -$7.05 |
